Beijing Science Sun Pharmaceutical Co., Ltd. (SZSE: 300485)
Health Care · Biotechnology · CN
CN¥9.91
-0.90% today · -31.8% 1Y
Beijing Science Sun Pharmaceutical Co., Ltd. (SZSE: 300485) operates in the Biotechnology industry within the Health Care sector. The company is valued at $710.06M and employs 489 people.
Over the last twelve months the share price has lost 31.8%, trading between 7.77 and 14.60.
Tweenvest scores Beijing Science Sun Pharmaceutical Co., Ltd. across four factors: quality 60/100, value 52/100, growth 0/100, dividend 35/100. Its strongest factor is quality.
300485 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $710.06M
- Revenue (TTM)
- $58.37M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- 3.03%
- Beta (5Y)
- 0.24
- 52-week high
- CN¥14.60
- 52-week low
- CN¥7.77
- Avg volume (3M)
- —
- Shares outstanding
- 481.67M
- Employees
- 489
- Next earnings
- —
About Beijing Science Sun Pharmaceutical Co., Ltd.
Beijing Science Sun Pharmaceutical Co., Ltd. is a company, established in 1999 and headquartered in Beijing, China, that operates within the Chinese pharmaceutical market. It is dedicated to the research, development, manufacturing, and distribution of injectable medications. The firm offers a wide array of products designed to treat conditions related to the cardiovascular, cerebrovascular, immunomodulatory, and nervous systems, among other health areas.
- ISIN
- CNE100002110
- Founded
- 1999
- Listed since
- Jun 26, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.85 | +0.34% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.50 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.50 | +0.26% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $842.16 | +0.97% |
| argenx SEENXTBR: ARGX | $65.85B | €880.20 | -2.42% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $142.57 | -1.72% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.